ERICA Webinar: REMEDI4ALL / drug repurposing and clinical trial readiness by Anton Ussi
October 2nd, from 13:00 to 14:00 CEST
This ERICA webinar will discuss challenges associated with getting ready for and conducting clinical trials in drug repurposing, with a focus on differences between trial requirements for future on-label or off-label use.
The discussion will also highlight key services and tools available to the community, as well as the REMEDi4ALL projects support offering.
Registration and more information, here
EJP-RD Variant Prioritization and Enrichment for Rare Diseases Workshop
September 20th-22nd, in Amsterdam UMC, Istanbul, Turkey
EJP-RD will organize a workshop on Variant Prioritization and Enrichment for Rare Diseases from September, 20th to 22nd 2023.
A three-day immersive event in which participants will learn the fundamentals of Whole Exome Sequencing (WES) including terminology, pre and post-alignment processing, variant calling using Genome Analysis Toolkit (GATK) pipeline and annotation/filtration/interpretation of the variants, and more!
Registration is open here until September 9th, 2023
More information, here
CMTC-OVM – 2023 Members conference
October 28th-29th, 2023 in the Netherlands and online
CMTC-OVM will organize their annual worldwide member’s conference in the Netherlands, on October 28th-29th, 2023. This year they will organize a ‘Hybrid’ conference again. This means that members can choose to participate Online/Virtual or be present In-Person at their location in the Netherlands.
For more information about the program and for registration, click here
ERICA & EJP-RD Joint Conference
November 21st, in Amsterdam UMC, Amsterdam, NL
ERICA and EJP-RD will organize their joint conference on November, 21st 2023. There will also be a pre-conference dinner on Monday 20th November.
During this meeting the will provide a close overview of all the relevant activities and joint efforts in the field of Rare Disease Research during the lifetime of EJP RD and ERICA with a further focus on the future RD Partnership & ERNs Research activities.
Registration and more information, here
GRIDD Study – Global Research on the Impact of Dermatological Diseases
From June 5th until September 28th
GlobalSkin in collaboration with Cardiff University (UK) and University Medical Centre Hamburg-Eppendorf (Germany) launches the Global Research on the Impact of Dermatological Diseases (GRIDD) Study.
The mission is to generate comprehensive global data about the impact of dermatological conditions affecting skin, hair, nails, and mucosa.
Take the survey by clicking here
For more information click here
EJP-RD advanced course: “Replicated N-of-1 Randomized Controlled Trials for Rare Diseases”
June 30th, at 4-6:30 pm CET
Fifth EJP-RD advanced course titled “Replicated N-of-1 Randomized Controlled Trials for Rare Diseases” held by Professor Patrick Onghena.
Panelists for the subsequent one-hour panel discussion:
- Dr. Alex Sverdlov, Novartis
- Prof. Dr. Matthieu Roustit, Université Grenoble Alpes, France
- Prof. Dr. Stephen Senn, retired
- Dr. Virginie Hivert, EURORDIS
Please note that preregistration is mandatory to secure your spot. Additional details, including how to register: EJP RD website.
Recordings of the previous EJP-RD webinars:
Webinar #1 “Does Randomization matter in clinical trials?” – presented by Prof. Dr. Ralf-Dieter Hilgers
Webinar #2 “Composite endpoints including patient relevant endpoints (Quality of Life)” – presented by Dr. Johan Verbeeck
Webinar #3 “The Statistical Evaluation of Surrogate Endpoints in Clinical Trials” – presented by Prof. Dr. Geert Molenberghs
Webinar #4 “Statistical and operational challenges with master protocols” – presented by Prof. Dr. Franz König
Take part in the Patient Partnership Framework Survey
Deadline: 25th June
EURORDIS invites you to take part in a survey to help develop a Patient Partnership Framework for the ERNs. The survey will take approximately 10 minutes to complete.
You may access the online survey here.
The aim of the Patient Partnership Framework is to formalise a guiding structure for all patient-clinician cooperation. For more information, please click here.
EJP-RD Advanced Course “Statistical and Operational Challenges with Master Protocols”
March 24th, at 4-6:30 pm CET
Join the upcoming fourth EJP-RD advanced course titled “Statistical and Operational Challenges with Master Protocols,” held by Professor Franz König. The course will take place on March 24th, 2023 at 4-6:30 pm CET.
Please note that preregistration is mandatory to secure your spot. Additional details, including how to register, can be found on the EJP RD website.
Art contest – Skin to skin
From February 28th 2023 to May 31st 2023
The René Touraine Foundation and its international network on Rare Skin Diseases have been organizing an international art contest since 2015: The Story of my Skin / Ma peau raconte. This year’s theme is Skin to Skin.
The aim of this event is to raise public awareness of rare skin diseases, to allow patients to express themselves and to encourage discussion. Please find more information here
Rare Diseases Day
World Diseases Day is a globally-coordinated movement on rare diseases, working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease.
- It was set up and is coordinated by EURORDIS and 65+ national alliance patient organization partners.
- It provides an energy and focal point that enables rare diseases advocacy work to progress on the local, national and international levels.
Please find more information here: https://www.rarediseaseday.org/what-is-rare-disease-day/
An European Medicines Agency (EMA) survey about the development of a multi-stakeholder platform to promote collaboration for improving clinical trials in the EU!
We have been asked by European Medicines Agency to inform you of the launch of a public consultation concerning the development of a multi-stakeholder platform to promote collaboration for improving clinical trials in the EU as foreseen by Accelerating Clinical Trials in the EU (ACT EU) priority action 3.
This platform will enable regular dialogue between all EU stakeholders on clinical trials, and facilitate the evolution of the clinical trials environment by helping to identify key advances in clinical trial methodologies, technology and science. The platform will serve as a neutral space for the discussion of challenges and the development of practical solutions to enable and drive change. It is envisaged that there will be several phases of development before reaching its final design.
A concept paper outlining the proposal for the creation of the platform has been published together with the public consultation. The objective of which is to gauge interest in the platform, get feedback on priority topics for discussion, and provide comments on the proposal. The multi-stakeholder platform will have its kick-off meeting in Q2 2023.
The public consultation can be accessed at the following survey EUSurvey – Survey (europa.eu) and will remain open until 03 March 2023 at midnight CET.
Those interested can find more information on the web page Accelerating Clinical Trials in the EU (ACT EU).
For any questions, stakeholders can contact ACTEU@ema.europa.eu
In this webinar, Viviana Giannuzzi, Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus will overview what should be done at the very least before starting a clinical trial in a study site. All the requirements will be discussed according to the role that an investigator may have in the trial. Some guidance and sources will be also provided.
More information about the Webinar, here.
Organised by ERICA in collaboration with EJP RD and ERN BOND
Additional information, registration and updates at ERICA website
Please submit any questions to ERICA WP4 team email@example.com or ERICA coordinating office
The workshop will deliverhttps://www.ejprarediseases.org/our-actions-and-services/training-and-education/ern-workshops/ expert knowledge on the following aspects of EB: clinical and genetic basis, wound and interdisciplinary management, how to design and conduct clinical trials, gene therapy, and models used in translational research.
End of March 2023 (Preliminary date)